Extracted text (via pymupdf)
18729 characters
Summary Federal Award Financial Information 19. Budget Period Start Date - End Date 20. Total Amount of Federal Funds Obligated by this Action 20a. Direct Cost Amount 20b. Indirect Cost Amount 21. Authorized Carryover 22. Offset 23. Total Amount of Federal Funds Obligated this budget period 24. Total Approved Cost Sharing or Matching, where applicable 25. Total Federal and Non-Federal Approved this Budget Period - End Date 26. Period of Performance Start Date 27. Total Amount of the Federal Award including Approved Cost Sharing or Matching this Period of Performance 28. Authorized Treatment of Program Income 29. Grants Management Officer – Signature Recipient Information Fe deral Agency Information 10.Program Official Contact Information Federal Award Information 30. Remarks 1. Recipient Name 9. Awarding Agency Contact Information Notice of Award Award# FAIN# Federal Award Date: Page 1 2. Congressional District of Recipient 3. Payment System Identifier (ID) 4. Employer Identification Number (EIN) 5. Data Universal Numbering System (DUNS) 6. Recipient’s Unique Entity Identifier (UEI) 7. Project Director or Principal Investigator 8. Authorized Official 11. Award Number 12. Unique Federal Award Identification Number (FAIN) 13. Statutory Authority 14. Federal Award Project Title 15. Assistance Listing Number 16. Assistance Listing Program Title 17. Award Action Type 18. Is the Award R&D? 08/01/2025 07/31/2026 ADDITIONAL COSTS 03 1866000472B9 Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC) 93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Supplement No $5,548,306.00 866000472 Mrs. Janice Downing Public Health Analyst jsb3@cdc.gov 404-639-7808 Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES 6 NU51CK000383-02-01 6 NU51CK000383-02-01 NU51CK000383 NU51CK000383 09/24/2025 CDC Office of Financial Resources Percy Jernigan Mr. John Lick Grant Unit Manager john.lick@maricopa.gov 602-372-0675 MARICOPA, COUNTY OF 4041 N Central Ave STE 1400 Phoenix, AZ 85012-3314 602-506-1829 Dr. Jessica White Jessica.White@Maricopa.gov 602-329-0254 $637,939.00 $84,287.00 07/31/2029 $2,321,118.00 $0.00 $1,598,892.00 $113,669.00 $0.00 301(A)AND317(K)(2)PHS42USC241(A)247B(K)2 602062515 LM85MG1513K5 Dr. Gwendolyn Demery Moore Grants Management Officer pne2@cdc.gov 404-498-2596 $722,226.00 08/01/2024 Page 2 33. Approved Budget (Excludes Direct Assistance) I. Financial Assistance from the Federal Awarding Agency Only II. Total project costs including grant funds and all other financial participation a. Salaries and Wages b. Fringe Benefits c. Total Personnel Costs d. Equipment e. Supplies f. Travel g. Construction h. Other i. Contractual j. TOTAL DIRECT COSTS INDIRECT COSTS TOTAL APPROVED BUDGET m. Federal Share n. Non-Federal Share 34. Accounting Classification Codes k. l. 31. Assistance Type 32. Type of Award Notice of Award Award# FAIN# Federal Award Date: Recipient Information Recipient Name Congressional District of Recipient Payment Account Number and Type Employer Identification Number (EIN) Data Universal Numbering System (DUNS) Recipient’s Unique Entity Identifier (UEI) $1,325,152.00 $486,242.00 $1,811,394.00 $0.00 $152,393.00 $5,600.00 $0.00 $16,286.00 $230,129.00 $2,215,802.00 $2,215,802.00 $218,985.00 $218,985.00 $2,434,787.00 $2,434,787.00 $2,434,787.00 $2,434,787.00 $0.00 $0.00 09/24/2025 6 NU51CK000383-02-01 NU51CK000383 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention MARICOPA, COUNTY OF 4041 N Central Ave STE 1400 Phoenix, AZ 85012-3314 602-506-1829 Cooperative Agreement 03 602062515 866000472 1866000472B9 Other LM85MG1513K5 FY-ACCOUNT NO. DOCUMENT NO. ADMINISTRATIVE CODE OBJECT CLASS ASSISTANCE LISTING AMT ACTION FINANCIAL ASSISTANCE APPROPRIATION 4-9211175 24NU51CK000383 CK 410Q 93.323 $0.00 75-24-0949 4-93904SH 24NU51CK000383 CK 410Q 93.323 $0.00 75-24-0959 4-93906N9 24NU51CK000383 CK 410Q 93.323 $0.00 75-24-0949 4-93908MV 24NU51CK000383 CK 410Q 93.323 $0.00 75-24-0949 4-9390BW5 24NU51CK000383 CK 410Q 93.323 $0.00 75-24-0958 4-9390ESB 24NU51CK000383 CK 410Q 93.323 $0.00 75-24-0949 4-9390JEN 24NU51CK000383NWSSC6 CK 410Q 93.323 $0.00 75-X-0140 4-9390L4J 24NU51CK000383 CK 410Q 93.323 $0.00 75-X-0949 4-9390MDR 24NU51CK000383 CK 410Q 93.323 $0.00 75-X-0951 4-9390MF2 24NU51CK000383 CK 410Q 93.323 $0.00 75-X-0949 4-9390MV4 24NU51CK000383JCVDC5 CK 410Q 93.323 $0.00 75-2124-0943 4-939ZVJC 24NU51CK000383 CK 410Q 93.323 $0.00 75-24-0949 4-9390MMY 24NU51CK000383JCVDC5 CK 410Q 93.323 $0.00 75-2124-0943 4-9390NGN 24NU51CK000383ETORC3 CK 410Q 93.323 $0.00 75-2024-0140 4-9390NXU 24NU51CK000383NWSSC5 CK 410Q 93.323 $0.00 75-2124-0943 4-939ZSKU 24NU51CK000383 CK 410Q 93.323 $0.00 75-24-0949 5-9390BW5 24NU51CK000383 CK 410Q 93.323 $0.00 75-25-0958 5-9390ESB 24NU51CK000383 CK 410Q 93.323 $0.00 75-25-0949 5-9390MC6 24NU51CK000383 CK 410Q 93.323 $0.00 75-X-0951 5-9390MDB 24NU51CK000383 CK 410Q 93.323 $0.00 75-25-0959 5-9390MDQ 24NU51CK000383 CK 410Q 93.323 $0.00 75-X-0951 5-9211175 24NU51CK000383 CK 410Q 93.323 $76,420.00 75-25-0949 5-939014P 24NU51CK000383 CK 410Q 93.323 $6,758.00 75-25-0949 5-93901JT 24NU51CK000383 CK 410Q 93.323 $9,598.00 75-25-0949 5-93906N9 24NU51CK000383 CK 410Q 93.323 $191,867.00 75-25-0949 5-93908MV 24NU51CK000383 CK 410Q 93.323 $417,583.00 75-25-0949 5-9390NYQ 24NU51CK000383 CK 410Q 93.323 $20,000.00 75-X-0949 Direct Assistance BUDGET CATEGORIES PREVIOUS AMOUNT (A) AMOUNT THIS ACTION (B) TOTAL (A + B) Personnel $0.00 $0.00 $0.00 Fringe Benefits $0.00 $0.00 $0.00 Travel $0.00 $0.00 $0.00 Equipment $0.00 $0.00 $0.00 Supplies $0.00 $0.00 $0.00 Contractual $0.00 $0.00 $0.00 Construction $0.00 $0.00 $0.00 Other $0.00 $0.00 $0.00 Total $0.00 $0.00 $0.00 3 Page Notice of Award Award# FAIN# Federal Award Date: 09/24/2025 6 NU51CK000383-02-01 NU51CK000383 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention AWARD ATTACHMENTS MARICOPA, COUNTY OF 6 NU51CK000383-02-01 Terms and Conditions 1. Incorporation: In addition to the federal laws, regulations, policies, and CDC General Terms and Conditions for Non-research awards at https://www.cdc.gov/grants/documents/General- Terms-and-Conditions-Non-Research-Awards.pdf, the Centers for Disease Control and Prevention (CDC) hereby incorporates Notice of Funding Opportunity (NOFO) number CDC- RFA-CK-24-0002, entitled Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC), as may be amended, which are hereby made a part of this Non-research award, hereinafter referred to as the Notice of Award (NoA). Applicable Regulatory Provisions: Prior to October 1, 2025, this award is subject to 45 CFR 75 except for eight flexibilities from 2 CFR 200 adopted by HHS on October 1, 2024. After October 1, 2025, this award will be subject to any applicable provisions of 2 CFR 200 and 2 CFR 300. Termination: Prior to October 1, 2025, this award is subject to the termination provisions at 45 CFR 75.372. Starting on October 1, 2025, this award is subject to the termination provisions at 2 CFR 200.340. Pursuant to 2 CFR 200.340, the recipient agrees by accepting this award that continued funding for the award is contingent upon the availability of appropriated funds, recipient satisfactory performance, compliance with the terms and conditions of the award, and a decision by the agency that the award continues to effectuate program goals or agency priorities. Assurance of Compliance: The applicant hereby agrees that it will comply with Title VI of the Civil Rights act of 1964, as amended (codified at 42 U.S.C. 2000d et seq.), and all requirements imposed by or pursuant to the Regulation of the Department of Health and Human Services (45 CFR Part 80); Section 504 of the Rehabilitation Act of 1973, as amended (codified at 29 U.S.C. 794), and all requirements imposed by or pursuant to the Regulation of the Department of Health and Human Services (45 CFR Part 84); Title IX of the Education Amendments of 1972, as amended (codified at 20 U.S.C. § 1681 et seq.), and all requirements imposed by or pursuant to the Regulation of the Department of Health and Human Services (45 CFR Part 86); The Age Discrimination Act of 1975, as amended (codified at 42 U.S.C. § 6101 et seq.), and all requirements imposed by or pursuant to the Regulation of the Department of Health and Human Services (45 CFR Part 91); and Section 1557 of the Patient Protection and Affordable Care Act, as amended (codified at 42 U.S.C. § 18116), and all requirements imposed by or pursuant to the Regulation of the Department of Health and Human Services (45 CFR Part 92). Total Approved Funding is included in Summary Federal Award Financial Information on page 1 of the NOA. All future year funding will be based on satisfactory programmatic progress and the availability of funds. The federal award amount is subject to adjustment based on total allowable costs incurred and/or the value of any third-party in-kind contribution when applicable. AWARD INFORMATION Note: Refer to the Payment Information section for Payment Management System (PMS) subaccount information. Approved Component/Project Funding: The NOFO provides for the funding of multiple components under this award. Unless specifically noted (e.g., out of scope) any/all Budget Line Item (BLI) that is not funded should be considered ‘approved but unfunded’. Should additional funds become available in the budget period, the Program/Project may issue a revised Notice of Award (NOA) to fund these BLIs. Financial Assistance Mechanism: Cooperative Agreement Technical Review Notes: As this is the second round of financial assistance to support Budget Period 2 (BP2) Work Plan activities, recipients have already submitted responses to Technical Review Notes (TRNs) after receiving the first round of funding. After receiving the second round of financial support, should a recipient wish to amend responses to TRNs, a request can be submitted to ELC CAMP (elc@cdc.gov) to have the Program/Project Work Plan re-opened. The TRNs for newly funded Budget Line Items (BLIs) must be addressed in ELC CAMP no later than Monday, October 20 by 3:00pm ET. Once all TRNs are addressed, the Budget must be exported, using the ‘Export’ button and selecting ‘Full Export’, and uploaded in GrantSolutions via Grant Note to become part of the official record. Please note: If a Budget Line Item (BLI) has a TRN that states ‘Not approved’ and then mentions lacking details, then that BLI is restricted until the details requested are provided. The funding of the BLI provides the recipient access to the funds, once the conditions in the TRN are met; however, the authority to use the funds does not exist until after the TRN requirements are fully satisfied. Failure to submit the required information by the due date, October 20, 2025, will cause delay in programmatic progress; and may result in either not being eligible or having reduced financial assistance awarded in the Program/Project for Budget Period 3. Contact the assigned ELC Project Officer indicated in the NOA with any questions regarding this document or any follow up requirements and timelines set forth therein. Note: If a Program/Project did not award funding for Budget Period 2 (BP2), then the Technical Review Notes (TRNs) are intended to be informational only. If a TRN in ELC CAMP is flagged as needing a response, but no funding was awarded under the Program/Project, the recipient can simply enter ‘Noted’ to get the system to remove the flag on the Task List. Additionally, if a Program/Project did not award funding, the recipient is not responsible to complete any of the Required Tasks and/or Activities proposed in the Work Plan. Substantial Involvement by CDC: This is a cooperative agreement, and CDC will have substantial programmatic involvement after the award is made. Substantial involvement is in addition to all post-award monitoring, technical assistance, and performance reviews undertaken in the normal course of stewardship of federal funds. • CDC program staff will assist, coordinate, or participate in carrying out effort under the award, and recipients agree to the responsibilities as detailed in the NOFO and included below. Expanded Authority: The recipient is permitted the following expanded authority in the administration of the award. • Carryover of unobligated balances from one budget period to a subsequent budget period. Unobligated funds may be used for purposes within the scope of the project as originally approved. Recipients will report use, or intended use, of carried over unobligated funds in Section 12 “Remarks” of the annual Federal Financial Report. If the GMO determines that some or all the unobligated funds are not necessary to complete the project, the GMO may restrict the recipient’s authority to automatically carry over unobligated balances in the future, use the balance to reduce or offset CDC funding for a subsequent budget period, or use a combination of these actions. FUNDING RESTRICTIONS AND LIMITATIONS Notice of Funding Opportunity (NOFO) Restrictions: • Recipients may not use funds for research. • Recipients may not use funds for clinical care except as allowed by law. • Recipients may use funds only for reasonable program purposes, including personnel, travel, supplies, and services. • Generally, recipients may not use funds to purchase furniture. Any such proposed spending must be clearly identified in the budget. • Reimbursement of pre-award costs generally is not allowed unless the CDC provides written approval to the recipient. • Other than for normal and recognized executive-legislative relationships, no funds may be used for: o publicity or propaganda purposes, for the preparation, distribution, or use of any material designed to support or defeat the enactment of legislation before any legislative body. o the salary or expenses of any grant or contract recipient, or agent acting for such recipient, related to any activity designed to influence the enactment of legislation, appropriations, regulation, administrative action, or Executive order proposed or pending before any legislative body. • See Additional Requirement (AR) 12 for detailed guidance on this prohibition and additional guidance on anti-lobbying restrictions for CDC recipients. • The direct and primary recipient in a cooperative agreement program must perform a substantial role in carrying out project outcomes and not merely serve as a conduit for an award to another party or provider who is ineligible. Administrative Budget Requirements: Personnel: Recipients should provide an anticipated start date and name of personnel for position identified as vacant or to be named/determined in the TRN. The recipient must upload the required information via Grant Messages in Grant Solutions upon hire. Travel: Recipients should identify staff travel by position or name. The recipient must provide updated justification via Grant Messages in Grant Solutions prior to traveling. 1. Please provide internal policies if they relate to non-employee travel. The recipient must upload the required information via Grant Messages in Grant Solutions. Contractual: If any missing elements are identified in the TRN, the recipient should complete the following: 1. Elements 1-3 are required for approval of contract budget requests. If these elements are not known at the time the application is submitted, the cost will not be approved, and the recipient may submit these details as a prior approval request. 2. If elements 4-6 are not available at the time of application, recipients may submit the remaining details as they become available via GrantSolutions as a Grant Message. Note: For a detailed description of the required elements, please see the CDC Budget Preparation Guidelines. Funding Restriction(s): Project F: Emerging Issues funding is restricted for Budget Period 2. Details regarding the conditions under which the Budget Line Items (BLIs) may be used can be found in the Technical Review Notes (TRNs). The funding of the BLI provides the recipient access to the funds, once the conditions in the TRNs are met; however, the authority to use the funds does not exist until after the TRN requirements are fully satisfied. Indirect Costs: The recipient’s indirect costs issued with the original award remain in effect throughout the budget period unless otherwise changed in writing, by the Grants Management Officer. REPORTING REQUIREMENTS Work Plan Milestone Reporting: Work Plan Milestone progress reporting is due each quarter of the budget period in ELC CAMP. On or around the first day of the last month of the quarter (i.e., October 1, January 1, April 1, and July 1), ELC CAMP will be opened for Work Plan progress reporting. The reporting period will last the month and close on the first day of the first month of the following quarter (i.e., November 1, February 1, May 1, and August 1). Failure to submit the required information by the due dates may result in either not being eligible or having reduced financial assistance awarded in the Program/Project for Budget Period 3. Financial Reporting: Financial reporting is due each quarter of the budget period in ELC CAMP. On the 20th day of the month following the end of the quarter (i.e., November 20, February 20, May 20, and August 20) recipients must report their expenditures and unliquidated obligations (ULOs), by Program/Project, in ELC CAMP. To reduce reporting burden, for Programs/Projects whose awards are a combination of funding sources (e.g., regular budget authority and COVID funding), the financial reporting will be done on the cumulative Program/Project award amount and not by PMS document number. Failure to submit the required information by the due dates may result in either not being eligible or having reduced financial assistance awarded in the Program/Project for Budget Period 3. PAYMENT INFORMATION Payment Management System Subaccount: Funds awarded in support of approved activities have been obligated in a subaccount in the PMS, herein identified as the “P Account”. Funds must be used in support of approved activities in the NOFO and the approved application. The grant document number identified beginning on the bottom of Page 2 of the Notice of Award must be known to draw down funds.